PAIAR, FABIOLA
 Distribuzione geografica
Continente #
NA - Nord America 14.620
AS - Asia 6.736
EU - Europa 4.520
SA - Sud America 1.289
Continente sconosciuto - Info sul continente non disponibili 434
AF - Africa 358
OC - Oceania 14
AN - Antartide 1
Totale 27.972
Nazione #
US - Stati Uniti d'America 14.259
CN - Cina 2.330
SG - Singapore 1.932
IT - Italia 1.693
HK - Hong Kong 1.074
BR - Brasile 1.033
VN - Vietnam 653
SE - Svezia 590
DE - Germania 377
BG - Bulgaria 353
FR - Francia 288
GB - Regno Unito 274
CA - Canada 214
AT - Austria 204
RU - Federazione Russa 198
FI - Finlandia 197
IN - India 114
CI - Costa d'Avorio 106
JP - Giappone 102
AR - Argentina 89
TR - Turchia 87
BD - Bangladesh 72
NL - Olanda 69
ZA - Sudafrica 62
ID - Indonesia 57
MX - Messico 54
KR - Corea 53
PL - Polonia 51
SN - Senegal 41
IQ - Iraq 40
NG - Nigeria 38
EC - Ecuador 37
VE - Venezuela 37
PK - Pakistan 36
CO - Colombia 30
MA - Marocco 30
IE - Irlanda 29
ES - Italia 25
UA - Ucraina 24
UZ - Uzbekistan 23
CR - Costa Rica 22
CZ - Repubblica Ceca 21
CL - Cile 20
SA - Arabia Saudita 20
BE - Belgio 19
JM - Giamaica 19
KE - Kenya 19
CH - Svizzera 17
MY - Malesia 17
PY - Paraguay 15
IL - Israele 13
PH - Filippine 13
RO - Romania 13
EG - Egitto 12
DZ - Algeria 11
HN - Honduras 10
RS - Serbia 10
TN - Tunisia 10
UY - Uruguay 10
AU - Australia 9
AZ - Azerbaigian 9
GT - Guatemala 9
HU - Ungheria 9
LB - Libano 9
PE - Perù 9
PT - Portogallo 9
TW - Taiwan 9
BO - Bolivia 8
JO - Giordania 8
LT - Lituania 8
TT - Trinidad e Tobago 8
DO - Repubblica Dominicana 7
ET - Etiopia 7
IR - Iran 7
OM - Oman 7
AE - Emirati Arabi Uniti 6
EE - Estonia 6
NO - Norvegia 6
AL - Albania 5
CY - Cipro 5
KG - Kirghizistan 5
KZ - Kazakistan 5
LK - Sri Lanka 5
BH - Bahrain 4
BY - Bielorussia 4
DK - Danimarca 4
EU - Europa 4
GA - Gabon 4
GR - Grecia 4
LV - Lettonia 4
NP - Nepal 4
TH - Thailandia 4
BB - Barbados 3
LA - Repubblica Popolare Democratica del Laos 3
MG - Madagascar 3
ML - Mali 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PA - Panama 3
PS - Palestinian Territory 3
Totale 27.501
Città #
Ashburn 1.354
Shanghai 1.213
Woodbridge 1.174
Fairfield 1.113
Hong Kong 1.067
Singapore 1.058
San Jose 1.040
Houston 876
Ann Arbor 843
Dallas 780
Santa Clara 696
Chandler 584
Seattle 476
Cambridge 400
Wilmington 388
Sofia 350
New York 337
Beijing 323
Council Bluffs 282
Boardman 219
Los Angeles 218
Ho Chi Minh City 191
Vienna 191
Florence 170
Pisa 164
Princeton 149
Lawrence 137
Lauterbourg 133
Munich 131
Medford 127
London 126
Serra 113
Abidjan 106
Rome 106
Milan 104
Des Moines 99
Hanoi 99
Ottawa 96
Tokyo 89
Frankfurt am Main 88
São Paulo 84
Buffalo 76
Redondo Beach 75
Turku 66
Dearborn 62
Dong Ket 59
Vicopisano 57
Hefei 54
Istanbul 54
Lucca 49
San Diego 49
Nanjing 46
Dakar 41
Düsseldorf 40
Lancaster 40
Montreal 39
Pietrasanta 39
Seoul 39
Warsaw 39
Cascina 38
Lagos 38
Toronto 38
Chicago 33
Helsinki 33
Phoenix 33
Atlanta 31
Fuzhou 31
Orem 31
Bremen 30
Rio de Janeiro 29
Amsterdam 28
Boulder 28
Cape Town 27
San Francisco 27
Da Nang 25
Belo Horizonte 23
Columbus 23
Denver 23
Baghdad 22
Ogden 22
Quanzhou 22
Tashkent 22
Curitiba 21
Haiphong 21
Porto Alegre 21
Brasília 20
Bientina 19
Brooklyn 19
Dublin 19
Guangzhou 19
Poplar 18
Redwood City 18
Johannesburg 17
Massa E Cozzile 17
Nairobi 17
Paris 17
Chennai 16
Guayaquil 16
Manchester 16
Mexico City 16
Totale 19.202
Nome #
Stereotactic body radiotherapy with CyberKnife for cardiac malignancies 789
Association of Glutathione S-Transferase P-1 (GSTP-1) rs1695 polymorphism with overall survival in glioblastoma patients treated with combined radio-chemotherapy 292
Correction to: Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapy 270
From a waiting list to a priority list: A computerized model for an easy-to-manage and automatically updated priority list in the booking of patients waiting for radiotherapy 268
Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapy 259
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 244
The effectiveness of bevacizumab in radionecrosis after radiosurgery of a single brain metastasis 244
Qual è l’effetto della radioterapia sulla funzionalità deglutitoria nei pazienti con tumore del rinofaringe e orofaringe? Risultati a breve termine di uno studio prospettico 240
Corrigendum: Metabolic-imaging of human glioblastoma live tumors: a new precision-medicine approach to predict tumor treatment response early 228
Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: Is local therapy with hyaluronic acid of clinical benefit? 220
Bevacizumab for the Treatment of Radiation-Induced Cerebral Necrosis: A Systematic Review of the Literature 209
NAVIGATOR: A regional multimodal imaging biobank initiative powered by AI tools for precision medicine in oncology 207
Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy 205
Salvage Hypofractionated Radiotherapy in Combination with Bevacizumab in Patients with Recurrent High Grade Glioma: A Mono-institutional Experience 205
Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature 204
Numerical simulations of charge transport in low-pressure noble gases for ultra-high dose per pulse applications 201
Role of perfusion CT in the evaluation of functional primary tumour response after radiochemotherapy in head and neck cancer: Preliminary findings 200
IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients 194
Application of helical tomotherapy for the treatment of a right atrium angiosarcoma: A case report 194
Contouring of the pharyngeal superior constrictor muscle (PSCM): a cooperative study of the Italian Association of Radiation Oncology (AIRO) Head and Neck Group 193
Accelerated intensity-modulated external radiotherapy as a new technical approach to treat the index quadrant after conserving surgery in early breast cancer: a preliminary study 191
Survival outcomes following repeat surgery for recurrent glioblastoma: a single-center retrospective analysis 188
Prognostic role of internal jugular vein preservation in neck dissection for head and neck cancer 186
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial 186
Role of perfusion CT in the evaluation of metastatic nodal tumor response after radiochemotherapy in head and neck cancer: preliminary findings 185
Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgery 184
Clinical Outcomes of Stereotactic Body Radiotherapy in Oligometastatic Gynecological Cancer 184
Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy 182
Subtotal supracricoid laryngectomy: Changing in indications, surgical techniques and use of new surgical devices 182
Hypofractionation in prostate cancer: Radiobiological basis and clinical appliance 181
The role of clinicopathologic and molecular prognostic factors in the post-mastectomy radiotherapy (PMRT): a retrospective analysis of 912 patients 175
[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer 175
EP-1568 Long-term results of [18F] Fluorocholine PET/CT guided SBRT in patients with prostate cancer 175
Cancer Stem Cells and Glioblastoma: Time for Innovative Biomarkers of Radio-Resistance? 172
IOERT in Breast Cancer: Results of Ten-Year Follow-Up in an Italian Experience Confirm High Local Recurrence Rate 172
REDISCOVER guidelines for borderline-resectable and locally advanced pancreatic cancer: management algorithm, unanswered questions, and future perspectives 172
Tubular carcinoma of the breast: Outcome and loco-regional recurrence in 307 patients 172
Four-dimensional computed tomography in accelerated partial breast irradiation planning: single series from a phase III trial 171
Non-melanoma skin cancer treated with high-doserate brachytherapy and Valencia applicator in elderly patients: a retrospective case series 170
Non-melanoma skin cancer treated with high-dose-rate brachytherapy: A review of literature 170
The effects of radiation therapy fractionation on the sparing of healthy tissue in FLASH radiotherapy 169
Incorporating dose–volume histogram parameters of swallowing organs at risk in a videofluoroscopy-based predictive model of radiation-induced dysphagia after head and neck cancer intensity-modulated radiation therapy 169
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease 167
Accelerated Partial Breast Irradiation With IMRT: New Technical Approach and Interim Analysis of Acute Toxicity in a Phase III Randomized Clinical Trial 167
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 167
Benefit of Radiation Boost After Whole-Breast Radiotherapy 165
Alternating intravenous and oral vinorelbine plus epirubicin with pegfilgrastim as neoadjuvant treatment of locally advanced breast cancer 165
Adjuvant chemoradiotherapy (gemcitabine-based) in pancreatic adenocarcinoma: The Pisa University experience 165
Adjuvant trastuzumab in breast cancer: Experience from the University of Florence 165
Electron FLASH radiotherapy in vivo studies. A systematic review 163
Salvage stereotactic re-irradiation with CyberKnife for locally recurrent head and neck cancer: A single center experience 163
Different timing to use bevacizumab in patients with recurrent glioblastoma: Early versus delayed administration 163
Radiation-induced nausea and vomiting in head and neck cancer: Is it something worth considering in the intensity modulated radiotherapy era? "A narrative review" 163
Treatment of epithelioid sarcoma at the Royal Marsden Hospital 162
A new calculation method for the free electron fraction of an ionization chamber in the ultra-high-dose-per-pulse regimen 162
Surface imaging, portal imaging, and skin marker set-up vs. CBCT for radiotherapy of the thorax and pelvis 161
Definitive Radiotherapy for Primary Squamous Cell Carcinoma of the Vagina: Are High-Dose External Beam Radiotherapy and High-Dose-Rate Brachytherapy Boost the Best Treatment? Experience of Two Italian Institutes 159
Breast cancer in the elderly: Treatment of 1500 patients 158
Loco-regional recurrence in 2064 patients with breast cancer treated with mastectomy without adjuvant radiotherapy 158
Set-up errors in head and neck cancer treated with IMRT technique assessed by cone-beam computed tomography: a feasible protocol 158
Head and neck radiotherapy amid the COVID‑19 pandemic: practice recommendations of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 158
Low prevalence of K-RAS, EGF-R and BRAF mutations in sinonasal adenocarcinomas. Implications for anti-EGFR treatments 158
Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment 157
Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma 157
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 156
Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring 156
The effects of FLASH radiotherapy on in vitro lung cancer model: an insight into ROS implication 155
A new solution for UHDP and UHDR (Flash) measurements: Theory and conceptual design of ALLS chamber 155
New insights on clinical perspectives of FLASH radiotherapy: from low- to very high electron energy 154
A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: Clinical benefit is a plausible end point? 154
High-dose-rate brachytherapy for non-melanoma skin cancer using tailored custom moulds – a single-centre experience 154
Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1998 153
Surgical options in radiotherapy-failed early glottic cancer 153
Radiation-Related Dysphagia: From Pathophysiology to Clinical Aspects 153
Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma 153
Treatment of uterine sarcoma at the University of Florence from 1980-2001 152
Concomitant external-beam irradiation and chemotherapy followed by high-dose rate brachytherapy boost in the treatment of squamous cell carcinoma of the vagina: A single-center retrospective study 152
Adjuvant Radiotherapy in High-Risk Squamous Cell Carcinoma of the Vulva: A Two-Institutional Italian Experience 152
Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology 152
Image-guided Stereotactic Body Radiotherapy in Metastatic Prostate Cancer 152
ElectronFlash with triode-gun: an innovative device for the research on Flash radiotherapy 150
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease 150
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 150
Single-fraction flattening filter–free volumetric modulated arc therapy for lung cancer: Dosimetric results and comparison with flattened beams technique 150
Radiomics and liquid biopsy in oncology: the holons of systems medicine 150
Uterine sarcoma: twenty-seven years of experience 149
How does radiotherapy impact swallowing function in nasopharynx and oropharynx cancer? Short-term results of a prospective study Qual è l’effetto della radioterapia sulla funzionalità deglutitoria nei pazienti con tumore del rinofaringe e orofaringe? Risultati a breve termine di uno studio prospettico 148
Stereotactic Body Radiotherapy in Patients with Lung Oligometastases from Colorectal Cancer 148
Bipolar disorder treatments and ovarian cancer: A systematic review 148
Stage I seminoma of the testis: a bi-institutional retrospective analysis of patients treated with radiation therapy only 147
Quality of life after radical treatment of prostate cancer: Validation of the Italian version of the University of California-Los Angeles Prostate Cancer Index 147
Circulating tumour cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival 147
Squamous cell carcinoma (SCC) of the Pyriform sinus with multiple metachronous brain metastases, a case report 147
A bioconvergence study on platinum-free concurrent chemoradiotherapy for the treatment of HPV-negative head and neck carcinoma 145
Late treatment-related complications in 214 patients with extremity soft-tissue sarcoma treated by surgery and postoperative radiation therapy 145
Prognostic factors and clinical features in patients with leptominengeal metastases from breast cancer: A single center experience 145
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 145
Radiotherapy in the COVID-19 Pandemic Era 145
Outcome After Conservative Surgery and Breast Irradiation in 5,717 Patients With Breast Cancer: Implications for Supraclavicular Nodal Irradiation 144
Adjuvant radiotherapy in patients with pancreatic adenocarcinoma. Is it still appealing in clinical trials? A meta-analysis and review of the literature 144
Totale 17.938
Categoria #
all - tutte 80.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.413


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.422 0 0 25 69 277 231 56 83 78 50 122 431
2022/20232.166 246 287 169 147 247 285 26 153 399 9 164 34
2023/20241.444 82 114 149 226 150 273 66 50 38 52 73 171
2024/20256.264 93 202 59 329 444 579 1.295 262 602 698 640 1.061
2025/20267.642 435 1.023 909 934 740 546 949 396 403 784 294 229
2026/20271.812 355 1.044 413 0 0 0 0 0 0 0 0 0
Totale 27.972